The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo

被引：42
|
作者：
Keren, Aviad [1 ]
Shemer, Avner [1 ]
Ullmann, Yehuda [1 ]
Paus, Ralf [2 ,3 ]
Gilhar, Amos [1 ]
机构：
[1] Technion Israel Inst Technol, Fac Med, Flieman Med Ctr, Skin Res Lab, IL-31096 Haifa, Israel
[2] Univ Manchester, Ctr Dermatol Res, Inst Inflammat & Repair, Manchester, Lancs, England
[3] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
来源：
JOURNAL OF DERMATOLOGICAL SCIENCE | 2015年 / 77卷 / 01期
关键词：
MODEL;
D O I：
10.1016/j.jdermsci.2014.11.009
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [1] Discovery of Apremilast, a selective PDE4 inhibitor
    Man, Hon-Wah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [2] Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis
    Abdulrahim, Hunar
    Thistleton, Samuel
    Adebajo, Adewale O.
    Shaw, Tim
    Edwards, Christopher
    Wells, Alvin
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 1099 - 1108
  • [3] THE EFFECTS OF THE PDE4 INHIBITOR APREMILAST ON CELLULAR PHYSIOLOGY AND ETHANOL DRINKING
    Mangieri, R. A.
    Aziz, H. C.
    Roberts, A. J.
    Roberto, M.
    Morrisett, R. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 104A - 104A
  • [4] Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity
    Schafer, P. H.
    Parton, A.
    Capone, L.
    Cedzik, D.
    Brady, H.
    Evans, J. F.
    Man, H. -W.
    Muller, G. W.
    Stirling, D. I.
    Chopra, R.
    CELLULAR SIGNALLING, 2014, 26 (09) : 2016 - 2029
  • [5] Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
    Schett, Georg
    Sloan, Victor S.
    Stevens, Randall M.
    Schafer, Peter
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2010, 2 (05) : 271 - 278
  • [6] Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
    Moe Sakakibara
    Harunari Shimoyama
    Mami Nomura
    Chikako Nakashima
    Megumi Hirabayashi
    Yoshihiro Sei
    Yoshihiro Kuwano
    European Journal of Dermatology, 2019, 29 : 436 - 437
  • [7] Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
    Sakakibara, Moe
    Shimoyama, Harunari
    Nomura, Mami
    Nakashima, Chikako
    Hirabayashi, Megumi
    Sei, Yoshihiro
    Kuwano, Yoshihiro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (04) : 436 - 437
  • [8] Nonclinical genotoxicity and carcinogenicity profile of apremilast, an oral selective inhibitor of PDE4
    Wegesser, Teresa
    Coppi, Aldo
    Harper Jr, Tod
    Paris, Maria
    Minocherhomji, Sheroy
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2021, 125
  • [9] Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast
    Krase, Ifat Zerin
    Cavanaugh, Kevin
    Curiel-Lewandrowski, Clara
    JAMA DERMATOLOGY, 2016, 152 (03) : 348 - 350
  • [10] Novel systemic drugs for psoriasis: Mechanism of action for apremilast, a specific inhibitor of PDE4
    Schafer, Peter H.
    Day, Robert M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (06) : 1041 - 1042
12345